Low-density-lipoprotein particle size predicts a poor outcome in patients with atherothrombotic stroke

Journal of Clinical Neurology (Korea)

Volumn 11, Issue 1, 2015, Pages 80-86

  Song, Tae Jin ^a,b   Cho, Hyun Ji ^c   Chang, Yoonkyung ^a   Youn, Minjung ^a   Shin, Min Jeong ^d   Jo, Inho ^a   Heo, Ji Hoe ^b   Kim, Yong Jae ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Bupyeong gu   (South Korea)

^d Korea University   (South Korea)

Author keywords

Atherosclerosis; Lipoprotein; Low density lipoprotein particle size; Stroke outcome; Stroke severity

Indexed keywords

EID: 84923367125     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2015.11.1.80     Document Type: Article

References (30)

1. Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K, et al. Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Des 2011;17:4089-4110.
2. Rizzo M, Berneis K. Should we measure routinely the LDL peak particle size? Int J Cardiol 2006;107:166-170.
3. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002;43:1363-1379.
4. Björnheden T, Babyi A, Bondjers G, Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 1996;123:43-56.
5. Tribble DL, Rizzo M, Chait A, Lewis DM, Blanche PJ, Krauss RM. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Am J Med 2001;110:103-110.
6. Berneis K, Shames DM, Blanche PJ, La Belle M, Rizzo M, Krauss RM. Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter. Metabolism 2004;53:483-487.
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
8. Gentile M, Panico S, Mattiello A, Ubaldi S, Iannuzzo G, De Michele M, et al. Association between small dense LDL and early atherosclerosis in a sample of menopausal women. Clin Chim Acta 2013;426:1-5.
9. Rizzo M, Pernice V, Frasheri A, Di Lorenzo G, Rini GB, Spinas GA, et al. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrinol (Oxf) 2009;70:870-875.
10. Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, et al. LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. J Clin Lipidol 2007;1:583-592.
11. Barbagallo CM, Rizzo M, Cefalu’ AB, Noto D, Scimeca A, Castello A, et al. Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction. Am J Cardiol 2002;89:460-462.
12. Miwa K. Low density lipoprotein particles are small in patients with coronary vasospasm. Int J Cardiol 2003;87:193-201.
13. O’Neal DN, Lewicki J, Ansari MZ, Matthews PG, Best JD. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. Atherosclerosis 1998;136:1-8.
14. Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Bogavac-Stanojevic N, Gulan B, et al. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis 2010;210:548-554.
15. Gorelick PB. Primary and comprehensive stroke centers: history, value and certification criteria. J Stroke 2013;15:78-89.
16. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
17. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
18. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003;22:106-117.
19. Oh MS, Yu KH, Lee JH, Jung S, Ko IS, Shin JH, et al. Validity and reliability of a Korean version of the national institutes of health stroke scale. J Clin Neurol 2012;8:177-183.
20. Kim OY, Chung HK, Shin MJ. Higher levels of serum triglyceride and dietary carbohydrate intake are associated with smaller LDL particle size in healthy Korean women. Nutr Res Pract 2012;6:120-125.
21. Kim YJ, Lee SM, Cho HJ, Do HJ, Hong CH, Shin MJ, et al. Plasma levels of apolipoprotein E and risk of intracranial artery stenosis in acute ischemic stroke patients. Ann Nutr Metab 2013;62:26-31.
22. Shoji T, Hatsuda S, Tsuchikura S, Shinohara K, Kimoto E, Koyama H, et al. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis. Atherosclerosis 2009;202:582-588.
23. Lei C, Wu B, Liu M, Chen Y. Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke. J Stroke Cerebrovasc Dis 2014;23:1112-1117.
24. Chen GC, Liu W, Duchateau P, Allaart J, Hamilton RL, Mendel CM, et al. Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects. J Biol Chem 1994;269:29121-29128.
25. Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 1999;84:3212-3216.
26. Banfi C, Camera M, Giandomenico G, Toschi V, Arpaia M, Mussoni L, et al. Vascular thrombogenicity induced by progressive LDL oxidation: protection by antioxidants. Thromb Haemost 2003;89:544-553.
27. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
28. Chae JS, Kim OY, Paik JK, Kang R, Seo WJ, Jeong TS, et al. Association of Lp-PLA(2) activity and LDL size with interleukin-6, an inflammatory cytokine and oxidized LDL, a marker of oxidative stress, in women with metabolic syndrome. Atherosclerosis 2011;218:499-506.
29. Ridder DA, Schwaninger M. NF-kappaB signaling in cerebral ischemia. Neuroscience 2009;158:995-1006.
30. Kargman DE, Tuck C, Berglund L, Lin IF, Mukherjee RS, Thompson EV, et al. Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 1998; 139:391-399.